OBD · LONDON STOCK EXCHANGE ·
Oxford Biodynamics PLC
First pharma agreement for EpiSwitch Orion
Our AI’s take
Oxford BioDynamics will use EpiSwitch® Orion to analyse genotype data for Johnson & Johnson, aiming to identify biomarkers predictive of response to biologic…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.